Global Prothrombin Complex Concentrate (PCC) Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Prothrombin Complex Concentrate (PCC) Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
In Europe and United States market, key players of prothrombin complex concentrate (PCC) drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. The top one player hold a share about 58%. United States is the largest market, has a share about 47%, followed by Germany, and France, with share 13% and 12%, separately.
The Global Info Research report includes an overview of the development of the Prothrombin Complex Concentrate (PCC) Drug industry chain, the market status of Hemophilia B (Beriplex, Profilnine), Acquired Coagulation Factor Deficiency (Beriplex, Profilnine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prothrombin Complex Concentrate (PCC) Drug.
Regionally, the report analyzes the Prothrombin Complex Concentrate (PCC) Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prothrombin Complex Concentrate (PCC) Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Prothrombin Complex Concentrate (PCC) Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prothrombin Complex Concentrate (PCC) Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Beriplex, Profilnine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prothrombin Complex Concentrate (PCC) Drug market.
Regional Analysis: The report involves examining the Prothrombin Complex Concentrate (PCC) Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prothrombin Complex Concentrate (PCC) Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Prothrombin Complex Concentrate (PCC) Drug:
Company Analysis: Report covers individual Prothrombin Complex Concentrate (PCC) Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prothrombin Complex Concentrate (PCC) Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hemophilia B, Acquired Coagulation Factor Deficiency).
Technology Analysis: Report covers specific technologies relevant to Prothrombin Complex Concentrate (PCC) Drug. It assesses the current state, advancements, and potential future developments in Prothrombin Complex Concentrate (PCC) Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prothrombin Complex Concentrate (PCC) Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Prothrombin Complex Concentrate (PCC) Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Prothrombin Complex Concentrate (PCC) Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prothrombin Complex Concentrate (PCC) Drug, with price, sales, revenue and global market share of Prothrombin Complex Concentrate (PCC) Drug from 2019 to 2024.
Chapter 3, the Prothrombin Complex Concentrate (PCC) Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prothrombin Complex Concentrate (PCC) Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Prothrombin Complex Concentrate (PCC) Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prothrombin Complex Concentrate (PCC) Drug.
Chapter 14 and 15, to describe Prothrombin Complex Concentrate (PCC) Drug sales channel, distributors, customers, research findings and conclusion.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
In Europe and United States market, key players of prothrombin complex concentrate (PCC) drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. The top one player hold a share about 58%. United States is the largest market, has a share about 47%, followed by Germany, and France, with share 13% and 12%, separately.
The Global Info Research report includes an overview of the development of the Prothrombin Complex Concentrate (PCC) Drug industry chain, the market status of Hemophilia B (Beriplex, Profilnine), Acquired Coagulation Factor Deficiency (Beriplex, Profilnine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prothrombin Complex Concentrate (PCC) Drug.
Regionally, the report analyzes the Prothrombin Complex Concentrate (PCC) Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prothrombin Complex Concentrate (PCC) Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Prothrombin Complex Concentrate (PCC) Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prothrombin Complex Concentrate (PCC) Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Beriplex, Profilnine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prothrombin Complex Concentrate (PCC) Drug market.
Regional Analysis: The report involves examining the Prothrombin Complex Concentrate (PCC) Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prothrombin Complex Concentrate (PCC) Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Prothrombin Complex Concentrate (PCC) Drug:
Company Analysis: Report covers individual Prothrombin Complex Concentrate (PCC) Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prothrombin Complex Concentrate (PCC) Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hemophilia B, Acquired Coagulation Factor Deficiency).
Technology Analysis: Report covers specific technologies relevant to Prothrombin Complex Concentrate (PCC) Drug. It assesses the current state, advancements, and potential future developments in Prothrombin Complex Concentrate (PCC) Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prothrombin Complex Concentrate (PCC) Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Prothrombin Complex Concentrate (PCC) Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Beriplex
- Profilnine
- Octaplex
- Prothromplex
- Cofact
- Other
- Hemophilia B
- Acquired Coagulation Factor Deficiency
- CSL Behring
- Grifols
- Octapharma
- Prothya Biosolutions
- Takeda
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Prothrombin Complex Concentrate (PCC) Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prothrombin Complex Concentrate (PCC) Drug, with price, sales, revenue and global market share of Prothrombin Complex Concentrate (PCC) Drug from 2019 to 2024.
Chapter 3, the Prothrombin Complex Concentrate (PCC) Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prothrombin Complex Concentrate (PCC) Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Prothrombin Complex Concentrate (PCC) Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prothrombin Complex Concentrate (PCC) Drug.
Chapter 14 and 15, to describe Prothrombin Complex Concentrate (PCC) Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Prothrombin Complex Concentrate (PCC) Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Beriplex
1.3.3 Profilnine
1.3.4 Octaplex
1.3.5 Prothromplex
1.3.6 Cofact
1.3.7 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hemophilia B
1.4.3 Acquired Coagulation Factor Deficiency
1.5 Global Prothrombin Complex Concentrate (PCC) Drug Market Size & Forecast
1.5.1 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (2019-2030)
1.5.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CSL Behring Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Grifols Recent Developments/Updates
2.3 Octapharma
2.3.1 Octapharma Details
2.3.2 Octapharma Major Business
2.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Octapharma Recent Developments/Updates
2.4 Prothya Biosolutions
2.4.1 Prothya Biosolutions Details
2.4.2 Prothya Biosolutions Major Business
2.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Prothya Biosolutions Recent Developments/Updates
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Takeda Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG BY MANUFACTURER
3.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturer (2019-2024)
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Prothrombin Complex Concentrate (PCC) Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Prothrombin Complex Concentrate (PCC) Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Prothrombin Complex Concentrate (PCC) Drug Manufacturer Market Share in 2023
3.5 Prothrombin Complex Concentrate (PCC) Drug Market: Overall Company Footprint Analysis
3.5.1 Prothrombin Complex Concentrate (PCC) Drug Market: Region Footprint
3.5.2 Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Type Footprint
3.5.3 Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2030)
4.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2019-2030)
4.2 North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
4.3 Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
4.5 South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
5.2 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type (2019-2030)
5.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
6.2 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application (2019-2030)
6.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
7.2 North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
7.3 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
7.3.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
8.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
8.3 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
8.3.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
9.3.1 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
10.2 South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
10.3 South America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
10.3.1 South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
11.3.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
12.2 Prothrombin Complex Concentrate (PCC) Drug Market Restraints
12.3 Prothrombin Complex Concentrate (PCC) Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Prothrombin Complex Concentrate (PCC) Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prothrombin Complex Concentrate (PCC) Drug
13.3 Prothrombin Complex Concentrate (PCC) Drug Production Process
13.4 Prothrombin Complex Concentrate (PCC) Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prothrombin Complex Concentrate (PCC) Drug Typical Distributors
14.3 Prothrombin Complex Concentrate (PCC) Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Prothrombin Complex Concentrate (PCC) Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Beriplex
1.3.3 Profilnine
1.3.4 Octaplex
1.3.5 Prothromplex
1.3.6 Cofact
1.3.7 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hemophilia B
1.4.3 Acquired Coagulation Factor Deficiency
1.5 Global Prothrombin Complex Concentrate (PCC) Drug Market Size & Forecast
1.5.1 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (2019-2030)
1.5.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CSL Behring Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Grifols Recent Developments/Updates
2.3 Octapharma
2.3.1 Octapharma Details
2.3.2 Octapharma Major Business
2.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Octapharma Recent Developments/Updates
2.4 Prothya Biosolutions
2.4.1 Prothya Biosolutions Details
2.4.2 Prothya Biosolutions Major Business
2.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Prothya Biosolutions Recent Developments/Updates
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Takeda Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG BY MANUFACTURER
3.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturer (2019-2024)
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Prothrombin Complex Concentrate (PCC) Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Prothrombin Complex Concentrate (PCC) Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Prothrombin Complex Concentrate (PCC) Drug Manufacturer Market Share in 2023
3.5 Prothrombin Complex Concentrate (PCC) Drug Market: Overall Company Footprint Analysis
3.5.1 Prothrombin Complex Concentrate (PCC) Drug Market: Region Footprint
3.5.2 Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Type Footprint
3.5.3 Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2030)
4.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2019-2030)
4.2 North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
4.3 Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
4.5 South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
5.2 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type (2019-2030)
5.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
6.2 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application (2019-2030)
6.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
7.2 North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
7.3 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
7.3.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
8.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
8.3 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
8.3.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
9.3.1 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
10.2 South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
10.3 South America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
10.3.1 South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
11.3.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
12.2 Prothrombin Complex Concentrate (PCC) Drug Market Restraints
12.3 Prothrombin Complex Concentrate (PCC) Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Prothrombin Complex Concentrate (PCC) Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prothrombin Complex Concentrate (PCC) Drug
13.3 Prothrombin Complex Concentrate (PCC) Drug Production Process
13.4 Prothrombin Complex Concentrate (PCC) Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prothrombin Complex Concentrate (PCC) Drug Typical Distributors
14.3 Prothrombin Complex Concentrate (PCC) Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 6. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CSL Behring Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 11. Grifols Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Grifols Recent Developments/Updates
Table 13. Octapharma Basic Information, Manufacturing Base and Competitors
Table 14. Octapharma Major Business
Table 15. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 16. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Octapharma Recent Developments/Updates
Table 18. Prothya Biosolutions Basic Information, Manufacturing Base and Competitors
Table 19. Prothya Biosolutions Major Business
Table 20. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 21. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Prothya Biosolutions Recent Developments/Updates
Table 23. Takeda Basic Information, Manufacturing Base and Competitors
Table 24. Takeda Major Business
Table 25. Takeda Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 26. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Takeda Recent Developments/Updates
Table 28. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 29. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 31. Market Position of Manufacturers in Prothrombin Complex Concentrate (PCC) Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Prothrombin Complex Concentrate (PCC) Drug Production Site of Key Manufacturer
Table 33. Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Type Footprint
Table 34. Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Application Footprint
Table 35. Prothrombin Complex Concentrate (PCC) Drug New Market Entrants and Barriers to Market Entry
Table 36. Prothrombin Complex Concentrate (PCC) Drug Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 38. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 39. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 42. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 43. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 44. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 45. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2019-2024) & (US$/Unit)
Table 48. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2025-2030) & (US$/Unit)
Table 49. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 50. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 51. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 52. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 53. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2019-2024) & (US$/Unit)
Table 54. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2025-2030) & (US$/Unit)
Table 55. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 56. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 57. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 58. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 59. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 60. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 61. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 66. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 67. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 68. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 69. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 72. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 73. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 74. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 75. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 76. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 77. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 80. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 81. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 82. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 83. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 84. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 85. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 88. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 89. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 92. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 93. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Prothrombin Complex Concentrate (PCC) Drug Raw Material
Table 96. Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug Raw Materials
Table 97. Prothrombin Complex Concentrate (PCC) Drug Typical Distributors
Table 98. Prothrombin Complex Concentrate (PCC) Drug Typical Customers
Table 1. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 6. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CSL Behring Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 11. Grifols Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Grifols Recent Developments/Updates
Table 13. Octapharma Basic Information, Manufacturing Base and Competitors
Table 14. Octapharma Major Business
Table 15. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 16. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Octapharma Recent Developments/Updates
Table 18. Prothya Biosolutions Basic Information, Manufacturing Base and Competitors
Table 19. Prothya Biosolutions Major Business
Table 20. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 21. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Prothya Biosolutions Recent Developments/Updates
Table 23. Takeda Basic Information, Manufacturing Base and Competitors
Table 24. Takeda Major Business
Table 25. Takeda Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 26. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Takeda Recent Developments/Updates
Table 28. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 29. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 31. Market Position of Manufacturers in Prothrombin Complex Concentrate (PCC) Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Prothrombin Complex Concentrate (PCC) Drug Production Site of Key Manufacturer
Table 33. Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Type Footprint
Table 34. Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Application Footprint
Table 35. Prothrombin Complex Concentrate (PCC) Drug New Market Entrants and Barriers to Market Entry
Table 36. Prothrombin Complex Concentrate (PCC) Drug Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 38. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 39. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 42. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 43. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 44. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 45. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2019-2024) & (US$/Unit)
Table 48. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2025-2030) & (US$/Unit)
Table 49. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 50. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 51. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 52. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 53. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2019-2024) & (US$/Unit)
Table 54. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2025-2030) & (US$/Unit)
Table 55. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 56. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 57. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 58. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 59. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 60. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 61. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 66. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 67. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 68. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 69. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 72. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 73. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 74. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 75. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 76. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 77. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 80. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 81. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 82. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 83. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 84. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 85. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 88. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 89. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 92. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 93. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Prothrombin Complex Concentrate (PCC) Drug Raw Material
Table 96. Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug Raw Materials
Table 97. Prothrombin Complex Concentrate (PCC) Drug Typical Distributors
Table 98. Prothrombin Complex Concentrate (PCC) Drug Typical Customers
LIST OF FIGURES
Figure 1. Prothrombin Complex Concentrate (PCC) Drug Picture
Figure 2. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Type in 2023
Figure 4. Beriplex Examples
Figure 5. Profilnine Examples
Figure 6. Octaplex Examples
Figure 7. Prothromplex Examples
Figure 8. Cofact Examples
Figure 9. Other Examples
Figure 10. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Application in 2023
Figure 12. Hemophilia B Examples
Figure 13. Acquired Coagulation Factor Deficiency Examples
Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Prothrombin Complex Concentrate (PCC) Drug Average Price (2019-2030) & (US$/Unit)
Figure 18. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Prothrombin Complex Concentrate (PCC) Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Prothrombin Complex Concentrate (PCC) Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Prothrombin Complex Concentrate (PCC) Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Region (2019-2030)
Figure 56. China Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Prothrombin Complex Concentrate (PCC) Drug Market Drivers
Figure 77. Prothrombin Complex Concentrate (PCC) Drug Market Restraints
Figure 78. Prothrombin Complex Concentrate (PCC) Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Prothrombin Complex Concentrate (PCC) Drug in 2023
Figure 81. Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug
Figure 82. Prothrombin Complex Concentrate (PCC) Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Prothrombin Complex Concentrate (PCC) Drug Picture
Figure 2. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Type in 2023
Figure 4. Beriplex Examples
Figure 5. Profilnine Examples
Figure 6. Octaplex Examples
Figure 7. Prothromplex Examples
Figure 8. Cofact Examples
Figure 9. Other Examples
Figure 10. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Application in 2023
Figure 12. Hemophilia B Examples
Figure 13. Acquired Coagulation Factor Deficiency Examples
Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Prothrombin Complex Concentrate (PCC) Drug Average Price (2019-2030) & (US$/Unit)
Figure 18. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Prothrombin Complex Concentrate (PCC) Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Prothrombin Complex Concentrate (PCC) Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Prothrombin Complex Concentrate (PCC) Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Region (2019-2030)
Figure 56. China Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Prothrombin Complex Concentrate (PCC) Drug Market Drivers
Figure 77. Prothrombin Complex Concentrate (PCC) Drug Market Restraints
Figure 78. Prothrombin Complex Concentrate (PCC) Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Prothrombin Complex Concentrate (PCC) Drug in 2023
Figure 81. Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug
Figure 82. Prothrombin Complex Concentrate (PCC) Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
